Form EFFECT SharonAI Holdings Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 14, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SharonAI Holdings (SHAZ) Reiterated at Overweight by Cantor Fitzgerald Amid M3 Power Delays
- Duchenne Muscular Dystrophy Clinical Trials Update 2026: Phase-Wise Pipeline Status, Drug Profiles, and Key Developers by DelveInsight | Vertex Pharma, Bioleaders Corporation, Wave Life Sciences
- Advanced Melanoma Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share